ArticleInvestigational new drugs2019

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial.

Christian Dittrich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.